Steadman Philippon Research Institute

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Steadman Philippon Research Institute sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials 2 currently recruiting 1 completed early-phase tilt upper quartile by trial count

Steadman Philippon Research Institute: 7 sponsored US clinical trials, 2 recruiting.

Steadman Philippon Research Institute sponsors 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 1 completed. 0 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Osteoarthritis, Knee, with 2 trials.

Upper-quartile sponsor footprint

Steadman Philippon Research Institute sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

7 total, page 1 of 1

RECRUITING NA

Home-Based Leg Dexterity Trainer for Management of Knee Osteoarthritis

NCT07397806
RECRUITING Phase 1

Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan

NCT06108063
ACTIVE NOT RECRUITING Phase 1

Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan

NCT05025956
ACTIVE NOT RECRUITING Phase 1

Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis

NCT04815902
ACTIVE NOT RECRUITING Phase 1

Prospective Evaluation of PRP and BMC Treatment to Accelerate Healing After ACL Reconstruction

NCT04205656
TERMINATED Phase 1

Losartan to Improve Hip Microfracture

NCT04212650
COMPLETED Phase 1

Senolytic Drugs Attenuate Osteoarthritis-Related Articular Cartilage Degeneration: A Clinical Trial

NCT04210986

Phase Distribution

PhaseTrial count
Phase 1 6

Therapeutic Areas

Osteoarthritis, Knee 2
Femoroacetabular Impingement 1
Knee Arthroplasty, Total 1
Osteoarthritis of the Knee 1

What is open in the Steadman Philippon Research Institute pipeline

2 recruiting of 7 indexed (29% open); 1 completed (14%).

Phase mix: 0 late (III/IV) vs 6 early (I/II) (early-phase heavy).

Top condition: Osteoarthritis, Knee (2 trials), 3 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Steadman Philippon Research Institute: open-pipeline peers nationwide

Peers matched on 7 registered trials and 29% open enrollment, not the therapeutic-area sidebar.

Steadman Philippon Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0102030405060 0%10%20%30%40% Total trials Recruiting share Steadman Philippon Research Institute3M4Life Research89bioAbbott Diagnostics DivisionAlabama Physical Therapy & AcupunctureAlloSourceAlnylam PharmaceuticalsAnnovis Bio
Steadman Philippon Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Steadman Philippon Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 trials (± recruiting share)

Sponsors near 29% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Steadman Philippon Research Institute page

7 registered trials is a research-attention snapshot, not an endorsement of Steadman Philippon Research Institute or any single study.

  • 2 of Steadman Philippon Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Osteoarthritis, Knee is the condition Steadman Philippon Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Osteoarthritis, Knee trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Steadman Philippon Research Institute pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.